Related references
Note: Only part of the references are listed.DIAGNOSTIC OVERVIEW OF BLOOD-BASED DYSFERLIN PROTEIN ASSAY FOR DYSFERLINOPATHIES
Arunkanth Ankala et al.
MUSCLE & NERVE (2014)
Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases
Kavitha Siva et al.
NUCLEIC ACID THERAPEUTICS (2014)
Dysferlin at transverse tubules regulates Ca2+ homeostasis in skeletal muscle
Jaclyn P. Kerr et al.
FRONTIERS IN PHYSIOLOGY (2014)
Eteplirsen for the Treatment of Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2013)
The C2 Domains of Otoferlin, Dysferlin, and Myoferlin Alter the Packing of Lipid Bilayers
Naomi J. Marty et al.
BIOCHEMISTRY (2013)
Update on the Treatment of Duchenne Muscular Dystrophy
Louise R. Rodino-Klapac et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
In Vitro Correction of a Pseudoexon-Generating Deep Intronic Mutation in LGMD2A by Antisense Oligonucleotides and Modified Small Nuclear RNAs
Lorea Blazquez et al.
HUMAN MUTATION (2013)
Muscular dystrophy in dysferlin-deficient mouse models
Mark A. Hornsey et al.
NEUROMUSCULAR DISORDERS (2013)
UMD-DYSF, a novel locus specific database for the compilation and interactive analysis of mutations in the dysferlin gene
Gaelle Blandin et al.
HUMAN MUTATION (2012)
被撤回的出版物: Modular Dispensability of Dysferlin C2 Domains Reveals Rational Design for Mini-dysferlin Molecules (Retracted article. See vol. 292, pg. 12543, 2017)
Bilal A. Azakir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Dantrolene Enhances Antisense-Mediated Exon Skipping in Human and Mouse Models of Duchenne Muscular Dystrophy
Genevieve C. Kendall et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Ferlins: Regulators of Vesicle Fusion for Auditory Neurotransmission, Receptor Trafficking and Membrane Repair
Angela Lek et al.
TRAFFIC (2012)
Pure Intronic Rearrangements Leading to Aberrant Pseudoexon Inclusion in Dystrophinopathy: A New Class of Mutations?
Mouna Messaoud Khelifi et al.
HUMAN MUTATION (2011)
Proinflammatory Signals and the Loss of Lymphatic Vessel Hyaluronan Receptor-1 (LYVE-1) in the Early Pathogenesis of Laminin Alpha2-deficient Skeletal Muscle
Katherine E. Wardrop et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
Translational Research and Therapeutic Perspectives in Dysferlinopathies
Florian Barthelemy et al.
MOLECULAR MEDICINE (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Bcl-2 Inhibits the Innate Immune Response during Early Pathogenesis of Murine Congenital Muscular Dystrophy
Sheila Jeudy et al.
PLOS ONE (2011)
Dysferlin Forms a Dimer Mediated by the C2 Domains and the Transmembrane Domain In Vitro and in Living Cells
Li Xu et al.
PLOS ONE (2011)
Establishment of clonal myogenic cell lines from severely affected dystrophic muscles-CDK4 maintains the myogenic population
Guido Stadler et al.
SKELETAL MUSCLE (2011)
Therapeutic exon skipping for dysferlinopathies?
Annemieke Aartsma-Rus et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies
Ashish Dhir et al.
FEBS JOURNAL (2010)
Antisense Modulation of Both Exonic and Intronic Splicing Motifs Induces Skipping of a DMD Pseudo-Exon Responsible for X-Linked Dilated Cardiomyopathy
Paola Rimessi et al.
HUMAN GENE THERAPY (2010)
Efficient Bypass of Mutations in Dysferlin Deficient Patient Cells by Antisense-Induced Exon Skipping
Nicolas Wein et al.
HUMAN MUTATION (2010)
DYSFERLIN ASSOCIATES WITH THE DEVELOPING T-TUBULE SYSTEM IN RODENT AND HUMAN SKELETAL MUSCLE
Lars Klinge et al.
MUSCLE & NERVE (2010)
PCRTiler: automated design of tiled and specific PCR primer pairs
Alain L. Gervais et al.
NUCLEIC ACIDS RESEARCH (2010)
Characterization of Lipid Binding Specificities of Dysferlin C2 Domains Reveals Novel Interactions with Phosphoinositides
Christian Therrien et al.
BIOCHEMISTRY (2009)
Identification and characterisation of human dysferlin transcript variants: implications for dysferlin mutational screening and isoforms
Zacharias Aloysius Dwi Pramono et al.
HUMAN GENETICS (2009)
Membrane Repair Defects in Muscular Dystrophy Are Linked to Altered Interaction between MG53, Caveolin-3, and Dysferlin
Chuanxi Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
DMD pseudoexon mutations: Splicing efficiency, phenotype, and potential therapy
Olga L. Gurvich et al.
ANNALS OF NEUROLOGY (2008)
Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy
En Kimura et al.
HUMAN MOLECULAR GENETICS (2008)
Characterization of novel CAPN3 isoforms in white blood cells:: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis
L. Blazquez et al.
NEUROGENETICS (2008)
Dysferlin and muscle membrane repair
Renzhi Han et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Dysferlin in membrane trafficking and patch repair
Louise Glover et al.
TRAFFIC (2007)
From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis
Lars Klinge et al.
FASEB JOURNAL (2007)
AHNAR, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration
Yanchao Huang et al.
FASEB JOURNAL (2007)
Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy
M Sinnreich et al.
NEUROLOGY (2006)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display
YC Huang et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
Dysferlin interacts with affixin (β-parvin) at the sarcolemma
C Matsuda et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Limb-girdle muscular dystrophies - from genetics to molecular pathology
SH Laval et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2004)
Dysferlin interacts with Annexins A1 and A2 and mediates sarcolemmal wound-healing
NJ Lennon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
A Aartsma-Rus et al.
HUMAN MOLECULAR GENETICS (2003)
Predictive identification of exonic splicing enhancers in human genes
WG Fairbrother et al.
SCIENCE (2002)
The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle
C Matsuda et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
